Abbvie reported $32.52B in Current Liabilities for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
ALKERMES ALKS:US $ 438.52M 23.84M
Amgen AMGN:US $ 12618M 268M
Astrazeneca AZN:US $ 21815M 925M
AstraZeneca AZN:LN 21815M 925M
Biogen BIIB:US $ 5018M 1071.4M
Biomarin Pharmaceutical BMRN:US $ 464.73M 25.69M
Bristol Myers Squibb BMY:US $ 20915M 1906M
Chemocentryx CCXI:US $ 68.81M 5.79M
Coherus Biosciences CHRS:US $ 140.75M 12.99M
Eisai 4523:JP Y 301894M 11439M
Eli Lilly And LLY:US $ 15620.6M 2234.6M
Endo International Ordinary Shares ENDP:US $ 1376.14M 253.82M
Gilead Sciences GILD:US $ 9220M 662M
GlaxoSmithKline GSK:LN 37835M 13557M
Horizon Pharma HZNP:US $ 791.06M 34.12M
Infinity Pharmaceuticals INFI:US $ 13.39M 0.09M
Intercept Pharmaceuticals ICPT:US $ 151.43M 0.39M
JAZZ PHA JAZZ:US $ 705.44M 31.97M
Medtronic MDT:US $ 12394M 3467M
Neurocrine Biosciences NBIX:US $ 285.7M 32.2M
Novartis NOVN:VX SF 27646M 2161M
Pacira Pharmaceuticals PCRX:US $ 133.18M 171.89M
Perrigo Ordinary Shares PRGO:US $ 981.3M 606.6M
Regeneron Pharmaceuticals REGN:US $ 3033.9M 26.3M
Revance Therapeutics RVNC:US $ 71.07M 3.78M
Teva Pharmaceutical Industries TEVA:US $ 10996M 617M
Ultragenyx Pharmaceutical RARE:US $ 220.64M 53.4M
United Therapeutics UTHR:US $ 331.5M 38.9M
Vertex Pharmaceuticals VRTX:US $ 2556.2M 376M
Zoetis ZTS:US $ 3051M 17M